Our initial GFAP immunoreactivity results suggested degeneration of GFAP labelled macroglia in the post-mortem human retina, which seemed at odds with reports of increased GFAP immunoreactivity in AD brain tissues compared to controls [60, 85]. Here, GFAP is linked to Alzheimer disease.